AM-Pharma

Industry · 12 registered clinical trials.

Status	Trial	Phase	Started
Completed	Ilofotase Alfa for Prevention of Renal Damage After Cardiac Surgery Open Heart Surgery	Phase 2	2023-12-19
Completed	Pilot Trial of Single Dose Ilofotase Alfa in Hypophosphatasia Hypophosphatasia	Phase 1 / Phase 2	2023-05-15
Completed	Recombinant Human Alkaline Phosphatase in Healthy Japanese Subjects Healthy	Phase 1	2021-05-07
Terminated	(Revival) Study to Investigate the Efficacy and Safety of Alkaline Phosphatase in Patients With Sepsis-Associa Acute Kidney Injury Due to Sepsis	Phase 3	2020-11-02
Completed	A Safety, Tolerability, Efficacy and QoL Study of Human recAP in the Treatment of Patients With SA-AKI Acute Kidney Injury	Phase 2	2014-12-18
Withdrawn	A Study on the Tolerability and Early Efficacy of hLF1-11 in Patients With Bacteremia Due to S. Epidermidis Staphylococcal Infections, Bacteremia	Phase 1 / Phase 2	2009-02-01
Withdrawn	Safety of hLF1-11 for the Treatment of Infectious Complications Among HSCT Recipients Fungal Infection, Bacterial Infection	Phase 1 / Phase 2	2008-11-01
Withdrawn	A Study on the Tolerability and Early Efficacy of hLF1-11 in Patients With Proven Candidaemia Candidaemia	Phase 1 / Phase 2	2008-07-01
Terminated	A Study in Sepsis Patients With Renal Failure Sepsis, Bacterial Infections and Mycoses	Phase 2	2008-05-01
Completed	Safety/Efficacy Study of Bovine Intestinal Alkaline Phosphatase in Patients With Moderate to Severe Ulcerative Ulcerative Colitis	Phase 2	2006-05-01
Completed	Safety of a Single Dose of 5 mg of hLF1-11 Given to Autologous Haematopoietic Stem Cell Transplant Recipients Hematopoietic Stem Cell Transplantation, Bacterial Infections and Mycoses	Phase 1 / Phase 2	2006-03-01
Completed	Bovine Intestinal Alkaline Phosphatase for the Treatment of Patients With Sepsis Sepsis, Multiple Organ Dysfunction Syndrome	Phase 2	2004-09-01